chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patient reported chest pain since couple of days after receiving vaccine. She did feel achy the following day. md had her take meloxicam for pain.  It was not helping so md gave rx for colchicine. She stated she is doing better but still having chest pain. Pt was diagnosed with pericarditis. She has experienced some abdominal pain possibly due to meloxicam. md is treating for 3 months to control inflammation around heart.
.2ml FLUMIST inadvertently administered instead of .25ml FLUZONE IM. Mom with pt & aware. Health System incident report completed. No adverse events noted.
Insomnia for one night; pain in left arm for 2 days; nausea for 2 days; severe vomiting for 24 hours (unable to keep down any solids or liquids); mild vomiting for another 24 hours; mild fever (1 degree above normal temperature); chills for 24 hours; general muscle pain across body for 2 days. Treatment: Took Acetaminophen as directed for two days; took melatonin to be able to sleep the day after the vaccine.
This case was reported by a consumer and described the occurrence of fever in a adult female patient who received SHINGRIX. Concurrent medical conditions included Crohn's disease (Crohn's disease and is on medications which suppress my immune system). On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fever, chills, muscle pain, influenza-like symptoms and adverse event. On an unknown date, the outcome of the fever was recovered/resolved and the outcome of the chills, muscle pain, influenza-like symptoms and adverse event were unknown. It was unknown if the reporter considered the fever, chills, muscle pain, influenza-like symptoms and adverse event to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The patient had a fairly bad reaction to the SHIGRIX vaccine, she had all of the possible side effects that were listed, including fever, chills, muscle aches, flu-like symptoms, etc. The fever lasted on an off for about 3 days. The patient has Crohn's disease and she was on medications which suppressed her immune system. The patient's doctor told her to contact to see what the company's recommendation was for people like her as far as getting the 2nd dose of the vaccine. The patient questioned about recommendation of the 2nd dose even if people had a bad reaction, the patient also want to know if the 2nd dose usually cause as bad of a reaction as the 1st dose.
Redness, pain, swelling at injection site and surrounding area. No fever present at time seen in clinic.
no additional AEs reported; GARDASIL 9 were administered to multiple unknown patients following temperature excursion; This non-valid, spontaneous report was received from an office manager and referred to multiple patients of unknown age and gender. The patients' concurrent conditions, concomitant therapies and medical history was not provided.  On an unknown date, multiple patients were vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, injection, 1 dose, lot # and expiration dates: 1775811, 07-DEC-2023; 1775827, 27-JUN-2024; W009829, 19-OCT-2024; U032681, 26-OCT-2023; and 1780876, 09-NOV-2023 (administration sites, and routes of administration were not provided) administered for prophylaxis.On unknown dates, the doses of vaccines experienced the temperature excursions of 8.55 Celsius degrees for 8 minutes and 9.29 Celsius degrees for 12 minutes (product storage error). There were no previous excursions reported. No additional adverse event (AE) details were reported (no adverse event).  This report is non-valid due to lack of patients' identifiers.  Follow-up information was received from an office manager on 10-MAY-2023:  The patient identifiers was updated such as date of birth, address and gender.  On 15-NOV-2022, the patient was vaccinated with one dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) pre-filled syringe, injection, 1 dose, lot # and expiration dates: 1775811, 07-DEC-2023; 1775827, 27-JUN-2024; W009829, 19-OCT-2024; U032681, 26-OCT-2023; and 1780876, 09-NOV-2023 (administration sites, and routes of administration were not provided) administered for prophylaxis.  Temperature excursion total time was 25 minutes. There was 3 temperature excursions: on 09-SEP-2022 for 8 minutes, on 16-SEP-2022 for 5 minutes and on 03-JAN-2023 for 12 minutes. Excursions were not noted until after the first fact due to employee error of cleaning data logger more than once a day.  The vaccines was purhased with public and privet founds and were given in private doctor's office/ hospital.The medication error occurred in the point of storage in clinical practice.  This is one of several report received from the same reporter.
Info has been received from an RN concerning an approximately 16 month old healthy female with no allergies, who on 10/22/93 was vaccinated with a dose of MMRII. On approximately 10/26/93 "within a few days", the pt developed a head to toe rash, which lasted for about 4 days. At that time, it was described as a fine raised red rash. Unspecified medical attention was sought. On approximately 10/30/93, the pt recovered. No product quality complaint was involved. Additional info has been requested. It was also reported, that the pt's twin sister was vaccinated with a dose of MMRII and experienced an adverse event.
I experienced rashes on most of my upper body. My arms, back, chest and hands. I'm having muscle aches in both of my arms. The rash has moved to my face and my eyes are swollen. I went to Urgent Care and was told to continue taking Zyrtec.
wheezing; elevated temp; throat felt like fire; This spontaneous case was reported by a consumer and describes the occurrence of WHEEZING (wheezing), BODY TEMPERATURE INCREASED (elevated temp) and THROAT IRRITATION (throat felt like fire) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On 26-Feb-2021, the patient experienced WHEEZING (wheezing), BODY TEMPERATURE INCREASED (elevated temp) and THROAT IRRITATION (throat felt like fire). At the time of the report, WHEEZING (wheezing), BODY TEMPERATURE INCREASED (elevated temp) and THROAT IRRITATION (throat felt like fire) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No Treatments were reported.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Additional information included onset date and outcome of the events.
According to parents sneezing, cough, congestion started immediately after Flumist given.
The client notified RN that he developed a rash on his "whole upper body" about 12 hours after receiving the 2nd COVID vaccine Pfizer. The client stated the rash was itchy, red, and had raised bumps. The client stated the rash resolved without medication after about 6 hours. The client denied any dizziness, shortness of breath, or other signs or symptoms of anaphylaxis.
Redness and swelling at front of upper arm no injection site reaction (right) patient advised to take diphenhydramine OTC and call doctor or go to hospital.
Pt received first dose of Pfizer lot EW0182 on May 26, 2021 and was sent to the 15 minute observation lot. Pt alerted staff in the lot and c/o neck pain, left side arm pain, upper left chest pain and some dizziness. Vitals stable: 134/72, HR 77, RR 16, PWD and Pulse ox 99%. EMS was called in non-emergent to assess the pt. Pt was feeling better at this point. Pt was assessed and released. No further action needed.
feeling unwell; diarrhea; tiredness; headache; chills; nausea; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 62 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 28Sep2021 10:00 (Lot number: 3013598) at the age of 62 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Diabetes" (ongoing), notes: Diabetes, She has been diabetic for the past couple of years. Her sugars are controlled. Concomitant medication(s) included: METFORMIN taken for diabetes mellitus (ongoing). The following information was reported: MALAISE (non-serious) with onset 29Sep2021, outcome "unknown", described as "feeling unwell"; DIARRHOEA (non-serious) with onset 29Sep2021, outcome "not recovered", described as "diarrhea"; FATIGUE (non-serious) with onset 29Sep2021, outcome "not recovered", described as "tiredness"; HEADACHE (non-serious) with onset 29Sep2021, outcome "recovered" (29Sep2021), described as "headache"; CHILLS (non-serious) with onset 29Sep2021, outcome "recovered" (29Sep2021), described as "chills"; NAUSEA (non-serious) with onset 29Sep2021, outcome "recovered" (29Sep2021), described as "nausea". Therapeutic measures were taken as a result of diarrhoea, fatigue, headache.  Additional information: Clinical course: It was reported that patient was still tired and diarrhea she is drinking water and apple Juice and wants to know if she can take Imodium. She has a doctor's appointment on the 07October. She has been drinking a lot of water and apple juice. Her doctor didn't prescribe the vaccine. She doesn't see her doctor until the 7th. When she got it she was fine. She was training at a withheld yesterday, and that is when she started feeling tired. She developed all of the side effects yesterday. She developed tiredness, headache, chills, diarrhea, and nausea yesterday. Today she just feels tired and has consistent diarrhea. Yesterday, she was tired with headache, nausea, and diarrhea. She has constant diarrhea. She is diabetic, but her sugar is controlled. She has been diabetic for the past couple of years. Her sugars are controlled though so she doesn't always take her Metformin. She talked to her doctor about it, and he agreed to only take it when needed. If she takes it every day her sugar will drop too low. She puts all of her metformin into a big bottle. So she doesn't have the normal prescription bottle. The big bottle is a pharmacy bottle from pharmacy. She took Tylenol for her headache yesterday.   No follow-up attempts are possible. No further information is expected.
fever; Headache; sweats; chills; nausea; weakness; aches; heat flashes; This is a spontaneous report from a contactable consumer or other non hcp.  A 20-years-old male patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Batch/Lot number ER8729 and expiration date: unknown)  via an unspecified route of administration on 06Apr2021  (at age of vaccination 20-years-old) as dose 1 Single for covid-19 immunisation . The patient medical history was not reported. There were no concomitant medications. The patient had covid prior vaccination and covid tested post vaccination was unknown. On 07Apr2021 patient experienced headache, sweats, chills, nausea, weakness, aches, heat flashes/fever. The outcome of event was unknown.  Follow-up #1 (09Apr2021): No significant information.   No follow-up attempts are possible. No further information is expected.
Morning after injection- soreness, warmth around injection site redness, swelling marks - 2 welts 4inches across arm. Did resolve after 3-4 day.
On 5/12/12 arm of patient, where Tdap was administered in left deltoid on 5/19/12 was dark red, swollen and tender to touch. The area described measured greater than 2 inches down the arm from the injection site and one inch across the upper arm. Fever reportedly on 5/20/12.
fever, chills, coughing up stuff, muscle spasms, fatigue, feels bad all over
Immediately following injection of HPV - 9, patient loss consciousness/slumped in chair for approximately 15 seconds. Recovered spontaneously.
Numbness on side of injection starting from under the ear, going down the neck into the arm. This lasted 3 days.
This case was reported by a nurse via call center representative and described the occurrence of bruising of arm in a 16-year-old female patient who received BEXSERO (batch number 151301A, expiry date unknown). On an unknown date, the patient received the 1st dose of BEXSERO .5 ml. On an unknown date, an unknown time after receiving BEXSERO, the patient experienced bruising of arm, nausea, fatigue and induration. On an unknown date, the outcome of the bruising of arm, nausea, fatigue and induration were not recovered/not resolved. It was unknown if the reporter considered the bruising of arm, nausea, fatigue and induration to be related to BEXSERO. Additional details were provided as follows: The age at vaccination was not reported. The patient experienced arm bruising, induration, nausea and fatigue. The patient was having difficult in carrying her day to day activities. The expiration date of the vaccine was erroneously reported as same as the patient's birth date. No further information was reported regarding the event.
Information has been received from a health care worker concerning himself. It was reported that in 1947 the patient was vaccinated with 2 doses of MMR II as a child. It was reported that in 2008 the patient may have received 2 additional doses of MMR II as an adult. The patient stated he was recently checked for titers and he did not have detectable antibodies for mumps. No further information is available.
Protruding tongue, Mild facial weakness, (R), No seizure. Baby seen yesterday for WCC and immunizations. Mother ICU RN noticed protruding tongue,still good suck, a little flaccid cheeks. This morning better tongue tone. No seizures, no tongue fasciculations. Denies temp. Breast feeding well, good suck.
18 teens in the State, had suffered "heart inflammation"; This case has been considered invalid ICH- Reporter with no first-hand knowledge  This is a spontaneous report from a Pfizer sponsored Program. A non-contactable consumer reported for 18 adolescents approx 12-15 years old, unspecified gender patients that :  Suspect Product(s):  Name:  Pfizer Covid Vaccine (BNT162B2)  Verbatim and event description: Please be aware I heard on yesterdays 11:00 o clock pm News Program with PRIVACY and PRIVACY a statement concerning receipt of Pfizer BioNtech COVID-19 vaccine. Among adolescents 12-15 years old who have received Pfizer-BioNtech COVID - 19 vaccine (not sure 1 or 2 doses), 18 teens in the State had suffered "heart inflammation" I have no further information, there was no other background information provided, and I have no first hand knowledge of any of the teens who suffered this adverse event.  No follow-up attempts are possible. Information about batch number cannot be obtained.  Follow-up (30May2021): This case remains invalid since since the reporter cannot be identified for direct/private contact (internet source)  This is a spontaneous report from a Pfizer sponsored Program. A non-contactable consumer of unspecified age or gender reported that:  Suspect Product(s):  Name:  Pfizer Covid Vaccine (BNT162B2) Verbatim and event description:  Could also be caused by an experimental gene therapy "vaccine"  No follow-up attempts are possible. Information about batch number cannot be obtained.
Chills; Nausea; Vomiting; Couldn't get out of bed; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 69 year-old female patient received bnt162b2 (BNT162B2), administration date 17Mar2021 (Lot number: ER2613) at the age of 69 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Acid reflux" (unspecified if ongoing), notes: Verbatim: Acid reflux; "COVID", start date: Dec2020 (unspecified if ongoing), notes: I had COVID in Dec. Concomitant medication(s) included: LIPITOR [ATORVASTATIN]; DEXILANT taken for gastrooesophageal reflux disease. The following information was reported: CHILLS (non-serious), outcome "unknown", described as "Chills"; NAUSEA (non-serious), outcome "unknown", described as "Nausea"; VOMITING (non-serious), outcome "unknown", described as "Vomiting"; BEDRIDDEN (non-serious), outcome "unknown", described as "Couldn't get out of bed". Therapeutic measures were taken as a result of chills, nausea, vomiting, bedridden.  Additional information: Consumer stated, she received it on 17Mar, her first dose and she got symptoms which she was really surprised because everybody was saying may that happens on the second but she got a reaction to it with the chills, nausea, vomiting, couldn't get out of bed but my question is she had Covid in Dec, she have had bad case of Covid in Dec and then she had the antibody infusion in Dec, she did wait my 90 days could that have played a part in her getting the reaction to the first dose. Consumer stated, "The only thing she took was Tylenol and she took Zofran for nausea. She was probably about a 172 pounds. Patient wanted to ask questions about whether or not my having the Covid previous because nobody else, it was a bunch that had and she was the only one that got a reaction and she was down for like 2 days so."  No follow-up attempts are possible. No further information is expected.
Pt complains of itching, redness, and bump at vaccine site on left deltoid which started last night. Pt useing hydrocortisone cream and was given oral Prednisone 10mg x 5 days.
Microemboli to toeson right foot, thrombophlebitis in the vein of the right arm
I95.9 HYPOTENSION 2/2/2022 CHF EXACERBATION, UNSPECIFIED R09.02 HYPOXIA 10/15/2021 CHF EXACERBATION, UNSPECIFIED R57.0 CARDIOGENIC SHOCK 2/2/2022 CHF EXACERBATION, UNSPECIFIED I95.9 HYPOTENSION 2/2/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED R09.02 HYPOXIA 10/15/2021 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED R57.0 CARDIOGENIC SHOCK 2/2/2022 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED I95.9 HYPOTENSION 2/2/2022 CHF EXACERBATION, UNSPECIFIED R09.02 HYPOXIA 10/15/2021 CHF EXACERBATION, UNSPECIFIED R57.0 CARDIOGENIC SHOCK 2/2/2022 CHF EXACERBATION, UNSPECIFIED
Hello, I did NOT have an adverse reaction to the vaccine (the only thing that happened was a bit of fogginess and fatigue for 1 day).   I reported in my V-safe check-in that health was worse now than prior to the vaccine, but that the worsening health was NOT a due to the vaccine. On July 27 I tested positive for covid (breakthrough case). My health is still not back to normal.  However, to be clear, I  feel that the vaccine saved my life. The vaccine was NOT part of my worsening health conditions. Thank you
This case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received SHINGRIX at an unknown dose. On an unknown date, unknown after receiving SHINGRIX, the patient experienced injection site swelling, injection site pain, injection site bruising and shoulder pain. On an unknown date, the outcome of the injection site swelling, injection site pain, injection site bruising and shoulder pain were unknown. It was unknown if the reporter considered the injection site swelling, injection site pain, injection site bruising and shoulder pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received SHINGRIX vaccine on left arm, which swelled and was very painful and bruised. The patient also experienced shoulder pain and there is a ball like knot which was formed clavicle.
redness, swelling and pain at injection site and formation of "white head" over injection site lasting 1 week.
she feels tight and heavy; Pain at the injection site; Swelling at the injection site; Patient reported that since receiving the injection she feels tight and heavy; Having hard time walking; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Patient reported that since receiving the injection she feels tight and heavy), GAIT DISTURBANCE (Having hard time walking), FEELING ABNORMAL (she feels tight and heavy), VACCINATION SITE PAIN (Pain at the injection site) and VACCINATION SITE SWELLING (Swelling at the injection site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced LIMB DISCOMFORT (Patient reported that since receiving the injection she feels tight and heavy), GAIT DISTURBANCE (Having hard time walking), VACCINATION SITE PAIN (Pain at the injection site) and VACCINATION SITE SWELLING (Swelling at the injection site). On an unknown date, the patient experienced FEELING ABNORMAL (she feels tight and heavy). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at a dose of 1 dosage form. At the time of the report, LIMB DISCOMFORT (Patient reported that since receiving the injection she feels tight and heavy), GAIT DISTURBANCE (Having hard time walking), FEELING ABNORMAL (she feels tight and heavy), VACCINATION SITE PAIN (Pain at the injection site) and VACCINATION SITE SWELLING (Swelling at the injection site) outcome was unknown.            The action taken with mRNA-1273(Moderna COVID-19 Vaccine) was not applicable  No treatment medications were reported
DEVELOPED CHILLS ON 1/6/21 LASTING 15 MINUTES BEFORE RESOLVING.
Received both FLUZONE and PNEUMOVAX in each arm. Arm where PNEUMOVAX was injected began to swell the next morning. Pain on scale 1-10 was reported 10. Went to hospital. Was given morphine drip due to the pain. Was discharged at 4pm and followed up with PCP. Elevated WBC and put on prednisone and abx. Pt still complaining on 10/9 of loss of mobilty in that arm.
Information has been received form a nurse referring to unspecified number of patients of unknown age and gender. Information about concurrent conditions, medical history and concomitant medication was not provided. On unknown dates the patients were vaccinated with VARIVAX (Merck) (lot# L020000, expiration date 02-JUN-2017; lot# L027287, expiration date 21-JUL-2017; lot# L021211, expiration date 10-JUN-2017) which were exposed to temperatures outside of the recommended range (incorrect product storage). No adverse effects have been reported. This is one of several reports received from the same source. Additional information has been requested.
The patient developed a red, papular rash on his check and experienced a rectal fever of 102.5F.